Measurement of Tricuspid Regurgitation Volume for Assessment of Tricuspid Regurgitation Using 3D Transesophageal Echocardiography

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05130775

Enrollment

Registered

2021-11-23

Start date

2022-08-05

Completion date

2022-08-05

Last updated

2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tricuspid Regurgitation

Brief summary

This study is a prospective observational chart review. The aim of the study is to evaluate tricuspid regurgitation volume using 3D volumetric assessment as an accurate method for tricuspid regurgitation severity in comparison to VCA.

Interventions

OTHERTransesophageal echocardiograpgy

3D acquisition of the right ventricle regurgitation volume

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

-All degrees of tricuspid regurgitation minimal, mild, moderate and severe will be included

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Tricuspid regurgitation volume	12 months	We will evaluate patients with different grades TR by both 3DVCA and the 3D volumetric approach

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026